http://www.biospectator.com/view/news_view.php?varAtcId=6438

Joint research with Bio-Pharm Solutions is evaluating the efficacy of the drug in zebrafish with epileptic seizure.

Woojung Bio announced on October 25 that it began epilepsy medicine screening using zebrafish jointly with Bio-Pharm Solutions, a CNS rare disease medicine developer.

IR/PR

The oral medication for infantile spasms (IS) is in phase 2 clinical trialsin Korea and the US, and the IV medication for status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2)… by expanding […]

IR/PR

The oral medication for infantile spasms (IS) is in phase 2 clinical trialsin Korea and the US, and the IV medication for status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2)… by expanding […]

Bio-Pharm Solutions

145, Gwanggyo-ro, Yeongtong-gu, Suwon,
Gyeonggi-do, 16229, Korea
6F, C Bldg, Advanced Institute of Convergence Technology

CONTACT

Tel: 82-31-888-9608
Fax: 82-31-888-9601

MORE

Careers: shkim@b-psol.com
Clinical Trials: hsshin@b-psol.com
Investor Inquiries: uklee@b-psol.com
BD Partnering: uklee@b-psol.com